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Diverse stimuli induce macrophages to become nonspecifically cytotoxic for 
transformed cells in vitro (1). Bacterial infections of mice by Bacillus Calmette 
Gu~rin  (BCG)  1 (2), protozoal infestations by Toxoplasma gondii  or Besnoitia 
jellisoni  (3), certain viral  infections (4), and  intraperitoneal  inoculations of 
bacterial lipopolysaccharides (LPS) (5) produce macrophages that injure trans- 
formed cells in vitro. In addition, macrophages obtained directly from tumors 
nonspecifically lyse transformed target cells (6-9).  Taken together, these data 
suggest a central role for stimulated macrophages both in host control of tumor 
cell proliferation and in the pathogenesis of the chronic inflammatory process. 
However,  the  mechanisms involved in  the  stimulation of macrophages, the 
generation of the lytic state,  and the mediation of target cell injury are not 
understood. Recently, we and others have shown that cytolytic properties can 
be induced in peritoneal macrophages by using LPS (10, 11) thereby offering the 
prospect of  examining how macrophages become stimulated, then injure tissues. 
The studies reported here investigate the nature of the interaction between LPS 
and murine macrophages that results in the generation of their capacity to kill 
tumor cells in a nonspecific manner. 
Materials  and Methods 
Preparations  of LPS.  The heptose-deficient mutant from Salmonella  minnesota  (R595) was 
grown in trypticase soy broth (Baltimore Biological Laboratories, Cockeysville,  Md.) under aerated 
conditions. Cells were harvested by centrifugation and washed twice with 0.85% sodium chloride. 
LPS from R595 was extracted and purified in our laboratory by Dr.  D.  C.  Morrison using the 
phenol-petroleum ether-chloroform procedure of Galanos et al.  (12). The water insoluble LPS 
extract was then sonicated and dissolved in 0.1% triethylamine. After extensive dialysis, the LPS 
preparation  of R595 was  stored  at  -70°C  until  required.  LPS from Escherichia  coli  serotype 
0111:B4 (ATCC 12015) was extracted by the phenol-water method of Westphal and Jann (13). 
Media  and  Cell  Lines.  Eagle's minimal  essential  medium  (MEM)  was  supplemented  by 
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glutamine  (2 raM),  sodium pyruvate (1  raM),  Hepes buffer (20 mM),  sodium bicarbonate 0.14%, 
heat inactivated (56°C, 30 rain) fetal bovine serum (FBS, Flow Laboratories, Inc., Rockville, Md.). 
penicillin (100,000 U/liter), and  streptomycin (100,000 /zg/liter) (Grand  Island Biological Com- 
pany, Grand Island, N.Y.) for use in tissue culture. RPMI-1640 medium (Flow Laboratories, Inc.) 
supplemented with glutamine (2 mM), 5% FBS, and 2 mercaptoethanol (5  x  10  -5 M) was used for 
studies of spleen cell mitogenesis. 
The DBA2 mouse mastocytoma line, P815, the C57 BL/6 mouse lympboma line EL-4 obtained 
from the Salk Institute tissue bank, and the BALB/c mouse lymphoma line Bd-1 (a gift from Dr. 
C.  J.  Peters of Scripps Clinic and  Research Foundation)  were maintained in  vitro by regular 
passage in Hepes MEM supplemtned with 10% FBS. 
Spleen cells from C57 BL/6 mice were prepared by disaggregation on a wire mesh into ice-cold 
Hepes MEM. After washing by centrifugation at 1,200 rpm for 10 rain at 4°C, a spleen cell count 
was performed on a sample of the cell suspension using a 1 in 10 dilution of 0.10% crystal violet 
acetic acid.  Petri dishes containing 1 x  l0  T spleen cells in RPMI medium supplemented by 5% 
heat-inactivated  FBS  were  incubated  for  48  h  at  37°C in  5%  CO2  in  air  before  being  used. 
Transformed B lymphocytes were produced by exposing the spleen cell suspensions to 10/zg/ml of 
LPS 0111:B4 fraction II during the 48-h incubation. Mouse erythrocytes from C57 BL/6 mice were 
washed three times by centrifugation at 4°C in Hepes MEM before being used as target cells. 
Macrophage Monolayers.  Female  C57  BL/6  mice,  8-  to  10-wk of age  (from  The  Jackson 
Laboratory, Bar Harbor, Maine) were injected intraperitoneally with 2 ml of thiogiycellate broth 
(BBL, Cockeysville, Md.) to be used as the source of elicited peritoneal macrophages (14). The 
resulting peritoneal exudate, which consisted of 80-90% macrophages, was harvested 5 days later 
by peritoneal lavage using Hepes MEM containing 10  U  per ml of sodium  heparin.  Aliquots 
usually consisting of 1.25 x 108 peritoneal exudate cells (PEC) were placed in the 16-ram diameter 
wells ofa Linbro plate (Flow Laboratories, Inc.). After 30 min at 37°C in 5% CO2 air, adherent cell 
monalayers were washed once with Hepes MEM and then incubated overnight in Hepes MEM + 
20% FBS. After two further washes and the addition of Hepes MEM + 20% FBS, the monolayers 
comprised over 95% of cells which were phagocytic for zymosan (ICN Pharmaceuticals Inc., Life 
Sciences Group, Cleveland, Ohio)  and which had the morphologic appearances of macrophages. 
For immunofluorescence studies,  macrophage monolayers were stained with F(ab)2 prepara- 
tions of fluoresceinated pelyvalent goat antiserum against purified mouse myeloma proteins of all 
major immunoglobulin classes and subclasses and rhodamine conjugated antiserum against brain 
associated  thymus  antigen  prepared  and  kind~  provided  by  Dr.  S.  Russell  (15). Washed 
macrophage  monolayers and  positive controls  consisting of spleen  cells adhered  to  a  plastic 
surface treated with poly L lysine (16) were stained and examined by using methods previously 
reported (15). 
LPS Stimulation  of Macrophages.  LPS was sonicated immediately before addition to macro- 
phage monolayers at appropriate concentrations either 24 h  before or at the same time as the 
target cells. 
Cytolytic Assay.  The cell lines P815, Bd-1, and EL-4 were labeled with 51 chromium (51Cr) in 
an identical fashion. Approximately 1 x  l0  T cells were suspended in a 50-ml plastic centrifuge 
tube  using  0.75 ml  of Hepes  MEM  +  20%  FBS.  Aliquots usually consisting of 5  x  104  cells 
representing about  8,000-10,000  cpm were added  to  appropriate  wells containing macrophage 
monolayers. Supernates were harvested at intervals after commencing incubation at 37°C in 5% 
CO2 air, spun at 400 g for 10 min, and transferred to tubes for counting in a T-scintillation counter 
(Searle Analytic Inc., Des Plaines, Ill.). Results were calculated as means of four replicates and 
then expressed as percent specific release by using the following calculation: 
experimental release -  macrophage control release  x 
specific  release  =  te~e c-c-~ss  -  ~e~e  I00. 
Macrophage control release  consisted of macrophage monolayers which were not treated with 
LPS. Morphological examination confirmed that specific  release  of  5~Cr  was associated  with overt 
destruction  of  target  cells.  Total releasable  counts  were obtained  from  the  supernate after  freezing 
and thawing of  labeled  cells  placed in Linbre wells and comprised about 90% of  the total  amount 
ofs~Cr added to  each  well.  Viability  of  macrophages after  LPS stimulation was assessed by  trypan 
blue  staining (Grand Island Biological  Co.). 
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600-1,200 rads in a Gammacell  40 (Atomic Energy of Canada) using a Cesium  137 source 
calibrated  to deliver 120 rads/min. Spleen cell  suspensions from irradiated  and control (unirra- 
diated)  mice diluted to a final  concentration of  2.5 × 106/mI in RPMI medium 5% FBS contain- 
ing 2-mercaptoethanol (5 × lff  5  M) and 200-~I  aliquots  placed in microtiter  wells (Falcon Plastics, 
Oxnard, Calif.).  Either  the  specific  T-cell  mitogen, concanavalin A (Pharmacia, Uppsala, Sweden) 
or the B-cell  mitogen, LPS 0111:B4 was added to appropriate wells.  After a 48-h incubation at 
37°C in  5% CO2 air,  the  wells were pulsed  overnight with i/~Ci  of  [3H]thymidine (sp  act  I mCi/16 
~g) (New England Nuclear Corp., Boston, Mass.). Cells  were harvested with a MASH  apparatus 
(Microbiological  Associates,  Walkersville, Md.). Filters  containing the  labeled  cells  were added to 
counting vials  containing 10 ml of  a one to  one mixture of  Aquasol-toluene and radioactivity  was 
counted in a/3-scintillation  counter (Searle  Analytic Inc.). 
Results 
Cytolytic Effect of LPS-Stimulated Macrophages on Tumor Cells.  To deter- 
mine whether LPS  stimulates  mouse peritoneal macrophages to  lyse tumor 
target cells in vitro,  LPS at a  final concentration of 25  gg/ml, was added to 
macrophage  monolayers  at  the  same  time  as  labeled  target  cells  and  the 
kinetics of radioactivity released into the supernate was followed for 32 h. After 
24 h  incubation, there was significant specific 51Cr release which increased to 
40% over the next 8 h  (Figs.  1 a  and 1 b).  However, when macrophages were 
incubated with LPS for 24 h  before the addition of target cells, cytolysis was 
significant after an 8 h incubation and increased linearly over the next 8 h until 
a plateau occurred at about 24 h. P815 tumor target cells incubated with LPS or 
added to macrophage monolayers not treated with LPS,  released radioactive 
counts with kinetics similar to those spontaneously lost from target cells alone 
(Fig. 1 a). Further experiments were performed to define the time required for 
the LPS to induce a cytolytic capacity in macrophages. In these experiments the 
preincubation times of LPS and macrophages varied from 32 to 4 h  before the 
addition of target cells, and lysis was assessed at regular intervals. The earliest 
cytolysis was measured 4 h  after the addition of labeled tumor cells when the 
preincubation period of LPS and macrophages had been 16 h or more (data not 
shown). 
To  examine  the  specificity,  if  any,  of  LPS-induced  macrophage  killing, 
macrophages preincubated with LPS were tested against the syngeneic lym- 
phoma cell line EL-4 and results compared to those seen when the allogeneic 
tumor cell lines P815 and Bd-1 were used. All three cell lines were lysed and the 
kinetics for specific release were similar showing that LPS-stimulated C57 BL/ 
6 macrophages can kill a syngeneic and several allogeneic tumor cell lines (Fig. 
2). 
Influence  of LPS  Concentration.  The  amount of LPS  required to  induce 
macrophages to lyse tumor cells was determined by preincubating macrophage 
monolayers for 24 h with concentrations of LPS ranging from 0.04 to 50 ~g/ml. 
The lysis of labeled target cells was subsequently measured at three time points 
over a 32-h period (Fig. 3 a). 10 and 25 #g/ml LPS produced maximal cytolysis 
and showed similar kinetics over 32 h but significant effects were also seen at 1 
and 5 ~g/ml (Fig. 3 a). The highest LPS concentration, 50 ~g/ml, was eventually 
toxic for macrophages, 40% of which failed to exclude trypan blue at the end of 
the 32-h incubation with target cells. By contrast, concentrations of LPS below 
25  ~tg/ml had minimal toxic effect, less than 5% of macrophages being killed WILLIAM  F.  DOE  AND  PETER  M.  HENSON  547 
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FIG. 1.  Kinetics of  cytolysis  of  5'Cr-labeled  P815 mastocytoma cells  from DBA/2 mice by 
C57BL/6 peritoneal  macrophages incubated with LPS-R595 at a concentration of  25 ~g/ml. 
(a)  Absolute radioactive  counts released into  supernate by 5 × 104  labeled P815 cells  added 
to  macrophages preincubated with LPS for  24  h (R595 M(1)  24 h, A), macrophages to  which 
LPS was added at the same time as target cells  (R595 M~  0 h, ©), untreated macrophage 
monolayers M(1)  control,  O, medium (P815D) and medium + LPS-R595 (P815 ÷ LPS, II). 
Data expressed as means of  quadruplicates _  1 SD shown by vertical  bars. Interrupted 
lines  indicate  kinetics  for controls.  (b) Data from Fig. 1 (a) expressed as percent specific 
release  calculated  as: 
experimental release  -  macrophage control  release 
total  releasable  counts -  macrophage control  release 
x  I00. 
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FIG. 2. Kinetics  of  cytolysis  of  the allogeneic  target  cell  lines,  P815 mastocytoma cells,  Bd-1 
lymphoma  cells,  and the syngeneic lymphoma  cell line EL-4 by 1  ×  10  e peritoneal 
macrophages preincubated with LPS-R595. Data expressed as  percent specific  release  from 
5 × 104  sICr-labeled  target  cells  calculated  from means of  four  replicates. 548  MACROPHAGE  STIMULATION  BY  BACTERIAL  LIPOPOLYSACCHARIDES.  I. 
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FIG.  3.  Dose-response curve for LPS-R595 stimulation of macrophages assayed by their 
cytolytic effect on 5  ×  104 51Cr-labeled P815 mastocytoma cells. All concentrations of LPS- 
11595 were preincubatod with 1  ×  10  e macrophages for 24 h  before the addition of target 
cells (a) kinetics over 32 h. Abscissa shows incubation time in hours after addition of I)815 
cells at time 0. (b) Cytolytic effect at concentrations of LPS-R595 from 0.04 to 50 ~g/ml at 16 
h after addition of P815 target cells. 
over the entire  incubation  period.  Concentrations  of LPS below 0.2  ~g/ml did 
not  induce  macrophage  monolayers  to  become  cytolytic  under  these  assay 
conditions (Fig. 3 a).  16 h after addition of labeled target cells, cytolysis curves 
for different concentrations of LPS showed maximal dose-response effects (Fig. 
3 b). 
Effect of  Altering the Ratio between Macrophages and Target Cells.  We used 
two methods to evaluate the relative importance  of the ratio between macro- 
phages  and  target  cells  to  the  lysis  of target  cells.  In  the  first,  a  constant 
number  of macrophages  (1  ×  l0  s)  was  plated  in  wells  to  produce  confluent 
monolayers and labeled Bd-1 cells were added to provide a macrophage to target 
cell ratio varying from 100:1 to 1:1. The Bd-1 lymphoma cell line was selected 
for these experiments because of its ability to grow exponentially at high cell 
densities.  Despite a  wide range in macrophage to tumor cell ratios, the curve 
describing specific release of radioactive counts showed significant killing at all 
ratios tested over 36 h  (Fig. 4 a). The second method involved adding a constant 
number of target  cells to wells containing  varying numbers of macrophages. 
Here,  a  different  relationship  between  macrophages  and  tumor  cells  was 
evident  (Fig.  4 b), even though the ratios were the same as before (Fig.  4 a). 
When macrophage numbers greater than 6 ×  105 per well were plated in the 16- 
mm wells, the monolayers were completely confluent and there was lysis over 
ratios varying from 11:1 (6  ×  105 macrophages) to 40:1  (2  ×  l0  s macrophages) 
(Fig. 4 b). When less than 6  ×  105 macrophages were added to the wells, target 
cell killing was not measurable even at a  macrophage to tumor cell ratio of 5 
and 10 to 1, contrasting with the marked cytolysis seen when' the same ratios 
were achieved on confluent macrophage monolayers  (Fig.  4 a).  These results 
indicate that the ratio of effector to target cell itself is less important to target 
cell  lysis  than  the  absolute  number  of macrophages  suggesting  that  either 
confluence  per  se  is  important  to  achieve  optimal  killing  of tumor  cells  or WILLIAM  F.  DOE  AND  plCTER M.  HENSON  549 
fO0" 
80~ 
2O 
100 
~80, 
w 
60 
u 
,~40 
20, 
a 
J 
1'o  2'o  1~o  ~,  ~  ~,  ~  ~'~9io  ~'o 
M¢/Tarlet  CeLl [Bd-1}  M¢/Tarl||t  Ceil IDd.1) 
Fro.  4.  Effect  of macrophage to target cell ratio on LPS-stimulated cytolysis of s~Cr- 
labeled Bd.1 lymphoma cells measured at 36 h  aider addition of target cells.  (a) Specific 
release of radioactivity when ratios were achieved by adding varying numbers of target 
cells from 1 x 10' to 1 x 10  e to confluent monolayere consisting  of I x  106 macrophages. (b) 
Cytolytic effect  produced  by  xarying macrophage  to  target  cell ratios  using constant 
numbers of Bd-1 target  ceUs (5  x  104) and  varying the  number of macrophages  in 
monolayers from 0.3 x 106 to 2 x 10  ~. 
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alternatively that  a  minimal  number  of macrophages  is  required  for  the 
generation of a soluble cytolytic factor or factors in sufficient concentration to 
kill target cells. 
Effect of Conditioned  Supernates from Macrophage  Monolayers  Incubated 
with LPS.  The following experiment was designed to test whether the condi- 
tioned culture medium from LPS-treated macrophages lysed the tumor cells. 
Supernates from wells containing macrophages preincubated with an optimal 
dose of LPS for 24 h  were centrifuged at 400 g  for 10 min and added to wells 
containing 5 x  104 labeled P815 as targets. No lysis was seen aider a 24-h period. 
By contrast, cytolysis was observed when target cells were added to control 
wells containing LPS stimulated macrophages (Table I). These results indicate 
that conditioned supernate alone is not capable of causing the cytolytic effect 
measured. 
Viability of LPS-Stimulated Macrophages after Killing Target Cells.  Mac- 
rophages harvested from mice inoculated with allogenic tumor cells retain their 
lytic capacity in vitro for a  sustained period and are capable of killing tumor 
target cells on repeated occasions (17). To determine whether LPS-stimulated 
macrophages behave similarly, we first incubated them with labeled target 
cells for 24 h, then aspirated the lysed target cells and supernate, and finally 
rechallenged the  same  monolayers of LPS-stimulated macrophages with  a 
second aliquot of 5  ×  104 target cells in fresh medium without LPS.  Marked 
specific  release  was  again  seen  after  24  h  (Table  II)  indicating that  LPS- 
stimulated macrophages are  capable  of repeated target  cell  killing  over  a 
sustained period in vitro. 
Effect of Lysed LPS-Stimulated  Macrophages  on  Tumor Cell  Viability  in 
Vitro.  To exclude the possibility that lysis of tumor cells by LPS-stimulated 
macrophages was due to loss of toxic products from injured macrophages, rather 
than the function of stimulated, fully viable macrophages, monolayers opti- 
mally stimulated by LPS were sonicated to cause their complete dissolution into 550  MACROPHAGE  STIMULATION  BY  BACTERIAL  LIPOPOLYSACCHARIDES.  I. 
TABLE  I 
Conditioned Supernates - Effects on Tumor Cell Viability 
P815 Target cells 
added to 
24 h Incubation  36 h Incubation 
51Cr  cpm  SR  5~Cr  cpm  SR 
%  % 
SN from LPS-MO  1,561 ± 56  0  2,140 ± 194  0 
SN from MO  1,615 ± 98  0  2,243 ± 100  0 
LPS + MO  3,072 ± 282  54  4,045 ± 100  80 
MO  1,222 ± 26  0  1,619 ±  160  0 
LPS  1,559 ± 114  0  2,183 ± 113  0 
Medium  1,600 ± 36  0  2,190 ± 50  0 
Total releasable cpm 4,634 ± 214. 
All cpm expressed as means _+ 1 SD of quadruplicates. 
Abbreviatons  used in this table: MO, peritoneal macrophages elicited with thiogly- 
collate; SR, specific release; SN, supernate. 
TABLZ  II 
Rechallenge of  LPS-Stimulated MO with Tumor Target Cells 
First 24 h incubation 
24 h Incubation with second 
challenge of P815 cells to 
same MO monolayers 
cpm slCr  SR  cpm  SR 
LPS + MO + P815  3,072 ± 242  54%  5,572 ± 472  89% 
M@ + P815  1,222 ± 26  -  2,797 ± 92  - 
P815  1,580 ± 74  -  2,937 ± 92  - 
LPS + P815  1,622 ± 92  -  2,907 ± 306  - 
Total releasable cpm  4,634 ± 214  -  5,922 ± 90  - 
All cpm expressed as means _  1 SD of quadruplicates. 
Abbreviations  used in this table: SR, specific release; MO, macrophages. 
conditioned  medium.  When  tumor  cells  were  added  to  the  sonicated  macro- 
phages and to parallel LPS-treated  monolayers of intact macrophages,  only the 
intact LPS-stimulated  macrophages  killed their targets  (Table III). 
The experiments  outlined above suggest that LPS stimulates macrophages  to 
develop a  sustained capacity to lyse tumor cell§ and to retain full viability over 
a  prolonged period of challenge with tumor cells. Moreover, the death or injury 
of stimulated  macrophages  does not appear relevant to the killing mechanism. 
Evidence  That  LPS  Acts  Directly  on  the  Macrophage  to  Induce 
Cytolysis.  Since  LPS  is a  potent  mitogen  for murine  B  cells  (18,  19),  it was 
important  to establish whether  the effect of LPS on macrophages  was direct or 
a  consequence  of stimulating  contaminating  adherent  B  cells present  in  the 
monolayer. There was also the remote possibility that contaminating  peritoneal 
T  lymphocytes,  sensitized  in  vivo  to  LPS,  were  contributing  to  the  observed 
target cell lysis. 
Therefore, the peritoneal exudate cells used as a  source of macrophages  were 
processed for adherence to plastic, washed,  and examined  for the presence of B 
and T  lymphocytes.  Over 95%  of the  cells comprising the monolayers  had  the WILLIAM  F.  DOE  AND  PETER  M.  HENSON  551 
TABLE III 
Effect of Macrophage Lysis on Tumor Cell Viability 
P815 Target cells  added to:  cpm 51Cr  SR 
% 
Sonicated LPS/MO  3,224 -+ 62  0 
LPS-MO  6,500 -+ 466  51 
MO  3,159 -+ 154  - 
All cpm expressed as means -+ 1 SD of quadruplicates. 
Abbreviations used in this table: SR, specific  release; MO, macrophages. 
morphologic appearance of  macrophages when viewed by phase contrast  micros- 
copy, and  after incubation with zymosan  particles over  95%  of the cells 
contained zymosan. When similarly prepared monolayers were stained  with 
F(ab)2 preparations of fluoresceinated rabbit anti-brain associated thymus 
antigen and rhodaminated anti-mouse immunoglobulin, no positively  stained 
cells  were seen in the 25 high power fields  examined for each stain.  Control 
preparations of  adherent spleen cells,  however, revealed the expected propor- 
tions  of  T and B lymphocytes when stained  by the same reagents.  Thus, there 
was no detectable  contamination of  the macrophage monolayers by adherent B 
or  T lymphocytes. 
A further  experiment was conducted to  determine whether macrophages from 
heavily irradiated  mice could be stimulated by LPS even though the mitogenic 
responses of  B and T lymphocytes had been abolished by the irradiation.  LPS 
stimulated macrophages from mice subjected to whole body irradiation  with 
600, 1,200,  and 2,400  rads 4  h before  PEC were harvested, and induced the same 
percentage of  target  cell  killing  as macrophages from the unirradiated control 
group  (Fig. 5). By contrast, the mitogenic  responses of splenic T  cells  to 
concanavalin  A  and of splenic B  cells  to LPS from the same animals were 
almost completely ablated in those mice subjected to 600 rads and higher 
irradiation  doses (Fig.  5). Taken together with the purity  of the macrophage 
monolayers,  these data suggest that LPS does not require the intermediary 
involvement  of B  or T  lymphocytes  to stimulate macrophages  to become 
cytolytic  for  tumor cells. 
LPS-Stimulated Macrophage Killing  is Tumor Specific.  As shown in Fig. 
2, LPS-stimulated  macrophages  kill a variety of tumor target cells,  both 
syngeneic and allogeneic.  The question then arose as to whether LPS-induced 
macrophage killing  was tumor specific,  as reported  for  macrophages stimulated 
in vivo by a variety of other agents  (1),  or whether target cells  devoid of 
neoplastic potential  were also susceptible.  Macrophage monolayers were opti- 
mally stimulated by LPS R595 and  then  5~Cr-labeled  normal spleen  cells,  spleen 
cells containing B lymphoblasts, mouse erythrocytes, or P815 cells at effector to 
target cell ratios of 1:1, 10:1, and 100:1 were added. While the P815 cells were 
lysed by the LPS-stimulated macrophage monolayers to  produce specific re- 
leases of 44, 54, and 48%, respectively, no detectable specific release of S~Cr was 
found  for  normal  spleen  cells,  spleen  cells  containing  B  lymphoblasts,  or 
erythrocytes.  These  results,  therefore,  suggest  that  the  cytolytic properties 
induced in macrophages by incubation with LPS are tumor cell specific and that 
nonneoplastic cells are not susceptible to lysis. 552  MACROPHAGE STIMULATION BY  BACTERIAL LIPOPOLYSACCHARIDES. I. 
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FIG. 5.  Whole  body  irradiation of mice. Effect  on LPS-induced  macrophage  cytolytic  effect 
when 5 × 10' ~:Cr-labeled P815 cells are added to 1 × l0  s macrophages  from mice irradiated 
with 0-2,400 rads. LPN-troated  monolayers  were proincuhated  for 24 h with LP8 1~95 ~g/ 
ml (m). Results expressed as percent of control where 100% represents specific release by 
LPS-treated macrophages from mice which were not irradiated. Uptake of [3H]thymidine 
pulse by spleen cells from  irradiated mice  stimulated by LPS-0111:B4 (O). Results  expressed 
as percent of  control where 100% represents uptake of [3H]thymidine  by 5 × 105 spleen cells 
stimulated by optimal  concentrations  of LPS-0111:B4 (1/~g/well)  or concanavalin  A (0.5 ~g/ 
well) achieved by constructing  dose-resl~nse curves for both mitogens. 
Discussion 
The experiments presented in this report detail the nature of the interaction 
by which LPS stimulates mouse peritoneal macrophages to kill tumor cells in 
vitro.  Macrophage stimulation by LPS seems to be independent of other cell 
types and results in the capacity to lyse both syngeneic and allogeneic tumor 
cell  lines.  In  the  accompanying paper  we  show  that  such  stimulation  of 
macrophages  is  a  general  property  of LPS  extracted  from  Gram-negative 
bacterial cell walls (20). Lysis of target cells by LPS stimulated macrophages is 
dependent  upon  the  absolute  number  of macrophages  required  to  produce 
confluent monolayers. 
The  kinetics of the  LPS-induced macrophage  cytolytic effect indicate two 
distinguishable components; a  latent period after LPS exposure before target 
cell killing is demonstrable and a second delay for maximal target cell lysis to 
occur.  The existence of a  latent period of more than  16  h  (Figs.  1 a  and b) 
suggests  that  this  period  may be  required  for  the  elaboration  of cytocidal 
function  in  macrophages  and  demands  study  using  appropriate  metabolic 
inhibitors.  An  additional time lag occurs before macrophages stimulated by 
LPS effect maximal lysis of tumor target cells. Even when labeled target cells 
are exposed to fully stimulated macrophages there is a linear increase in specific 
release  over  the  first  16-20  h,  the  time  required  for maximal  lysis.  These 
kinetics closely resemble those seen in identical assay conditions using macro- 
phages stimulated by intraperitoneally inoculating mice with allogenic tumor 
cells,  W.  F.  Doe,  unpublished observations.  Moreover,  similar cytolytic time 
curves have been demonstrated for in vitro tumor cell killing by macrophages 
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cell lysis by LPS  stimulated macrophages may involve the  same or a  very 
similar lytic mechanism to that of macrophages stimulated in vivo. 
LPS-stimulated macrophages were nonspecifically cytolytic for tumor cells, 
killing both syngeneic (EL-4) and allogeneic (Bd-1) lymphoma lines and the 
allogeneic mastocytoma  cell line, P815. Although the degree of killing varies for 
these different target cells, the time curves for lysis are very similar suggesting 
that  variations  in  specific  release  between  cell  lines  mainly  reflect  their 
sensitivities to lysis per se.  Only target cells with neoplastic potential were 
susceptible  to  lysis  by  LPS-stimulated  macrophages.  By  contrast,  when  a 
variety  of non-neoplastic  cells,  including  normal  spleen  cells,  spleen  cells 
containing a high proportion of B lymphoblasts or erythrocytes were offered as 
targets, no lysis was observed. These findings indicate that LPS treatment of 
macrophages in  vitro  induces  a  cytolytic state  similar to  that  reported for 
macrophages activated in vivo by BCG, protozoa, or tumor cells (1-3, 6-9). The 
nature of the non-immunologic recognition mechanism which determines sus- 
ceptibility to or protection from killer macrophages, however, remains to be 
elucidated. 
Even at favorable ratios between effector and target cells, a threshold number 
of macrophages was needed for cytolysis, apparently related to the number 
required  to  produce  confluent  monolayers.  Subconfluent  monolayers  were 
ineffective at lysing target cells at ratios as high as 10:1. Yet,  at similar or 
lower ratios of target cells added to confluent monolayers, significant target cell 
killing  occurred.  Several  interpretations of these  experiments are  possible. 
First,  if  membrane  apposition  between  macrophages  and  tumor  cells  is 
essential to target cell lysis, subconfluent macrophage monolayers may offer a 
reduced opportunity for such contact. Second, confluence may be necessary for 
information transfer between macrophages, perhaps representing a mechanism 
by which a  subpopulation of primed macrophages stimulates an entire mono- 
layer. A third alternative is that a  minimal number of macrophages may be 
required for the  generation of the  suprathreshold concentration of cytolytic 
factor(s) required to lyse tumor cells. 
We  then  showed  that  viable  LPS-stimulated  macrophages were  entirely 
responsible for lysing the tumor cells they contacted by showing that other 
possible factors did not participate. Conditioned supernates from wells contain- 
ing LPS-stimulated macrophage monolayers did not lyse target cells, nor were 
disrupted LPS-stimulated macrophages capable of inducing lysis.  Moreover, 
stimulated macrophages could kill on more than one occasion over a sustained 
period without further stimulation by additional LPS. These findings support 
the view that cell contact between effector and target cell is essential to achieve 
target cell lysis and suggest that if a  soluble lytic factor is secreted by the 
stimulated macrophage, it requires the microenvironment within close mem- 
brane apposition to be effective, and is not sufficiently active, or not present at 
adequate  concentration  for  the  conditioned  supernate  alone  to  have  lytic 
properties. Alexander and Evans reported similar findings for LPS stimulated 
macrophages in  a  cytostatic assay  in  which they failed to  detect a  growth 
inhibitory factor in supernates (5). Other workers have shown that only tumor 
cells in actual contact with macrophages stimulated by BCG (21), toxoplasma 
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suggested  that the mechanism  of macrophage  cytotoxicity involves direct 
transfer  of  subcellular  components across  the fused membranes of  a stimulated 
macrophage  and adherent target cell (23). However,  a number  of soluble 
macrophage cytotoxic  factors  with widely differing  properties  and specificities 
have been reported. Currie  and Basham  describe a factor nonspecifically 
cytolytic  for tumor cells  and inhibited  by FBS in supernates from LPS stimu- 
lated macrophages  (10).  This finding, together with those of soluble factors 
which are immunologically specific  (24)  or lytic  for erythrocytes (25)  may be 
reconciled with our results  if they reflect  molecular events occurring at the 
interacting  surfaces  of  stimulated killer  cells  and target  cells. 
Our  experimental  evidence  indicates that  LPS  stimulates macrophages 
directly  and does not require  the participation  of  B or  T lymphocytes. Immuno- 
fluorescence  staining  of  macrophage monolayers did not detect  contamination 
by adherent B or T lymphocytes. Moreover, high doses of irradiation  did not 
affect  the LPS induced macrophage cytolytic  capacity  even  though the mitogenic 
response of  similarly  irradiated  spleen  cells  to LPS and to Concanavalin A was 
completely abolished.  In addition,  Bona has shown that  labeled  LPS binds to, 
and is taken up by, macrophages  (26).  It seems likely,  therefore,  that LPS 
interacts  directly  with  macrophages to  stimulate  their  differentiation  into  killer 
cells. These findings contrast with those of Wilton et al. who  reported a 
requirement for B lymphocytes or supernates from stimulated B lymphocytes, 
in LPS stimulation of guinea pig macrophages using uptake of 14C glucosamine 
as an assay for stimulation (27). This difference may result from the fact that 
14C glucosamine uptake does not reflect the same functional state as a cytolytic 
assay or from a species difference in macrophage response to LPS. 
We have shown that thioglycollate elicited macrophages do not affect the 
viability of tumor cells in vitro unless the macrophage monolayer is stimulated 
by LPS (Fig.  1 a).  However, elicited macrophages differ significantly from the 
resident peritoneal macrophage population in their morphologic, biochemical, 
and functional attributes and apparently represent a  more differentiated cell 
population (14, 28-32). In this report, we have demonstrated that LPS stimu- 
lates further differentiation in elicited macrophages resulting in cellscapable of 
killing tumor cells.  Studies are therefore being undertaken to define the steps 
involved  in  the  differentiation of macrophages stimulated by  LPS. In  the 
accompanying paper we examine the biochemical nature of the  stimulation 
signal delivered by LPS. 
Summary 
Bacterial lipopolysaccharides (LPS) stimulate mouse peritoneal macrophages 
to  kill  tumor  cells  in  vitro.  Lysis  is  confned to  tumor  cells  where  it  is 
nonspecific; both allogeneic and syngeneic cells being susceptible. Stimulation 
by LPS appears to be due to direct interaction between LPS and macrophages 
and does not involve participation by lymphocytes. Aiter exposure to LPS, a 
latent period must elapse before macrophages can lyse tumor cells. The cytolytic 
mechanism requires contact between target cells and viable effector cells which 
maintain their lytic capacity for a  sustained period and can kill on repeated 
occasions. The generation of a macrophage cytolytic effect by LPS is critically WILLIAM  F.  DOE  AND  PETER  M.  HENSON  555 
dependent upon the absolute number of macrophages which must be suffcient 
to produce confluent monolayers. These findings indicate that LPS stimulation 
of macrophages in vitro represents a valuable model system for the study of the 
mechanisms  of macrophage  stimulation  and  of the  mediation  of tumor  cell 
death. 
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